Age related changes of free and total prostate specific antigen in serum

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2629-2632

  Wolff, Johannes M ^a   Borchers, H ^a   Rohde, D ^a   Jakse, G ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Age; Benign prostatic hyperplasia; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AGING; CHEMOLUMINESCENCE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN EXPERIMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; RURAL POPULATION; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGE FACTORS; AGED; AGING; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROTEIN BINDING; REFERENCE VALUES;

EID: 0032781048     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Oesterling JE: Prostate Specific Antigen: A critical assessment of the most useful tumour marker for adenocarcinoma of the prostate. J Urol 145: 907-923, 1991.
2. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH: Screening for prostatic carcinoma with prostate specific antigen. J Urol 147: 841-845, 1992.
3. Collins GN, Lee RJ, McKelvie GB, Rogers ACN, Hehir M: Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Br J Urol 71: 445-450, 1993.
4. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM: Serum prostate-specific antigen in a community based population of healthy men: establishment of age-specific reference ranges. JAMA 270: 860-864, 1993.
5. Dalkin BL, Ahmann FR, Kopp JB: Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma. J Urol 150: 1837-1839, 1993.
6. Babaian RJ, Miyashita H, Evans RB, Ramirez EI: The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age. J Urol 147: 837-840, 1992.
7. Wolff JM, Borchers H, Effert PJ, Habib FK, Jakse G: Free-to-total prostate- specific antigen serum concentrations in patients with prostate cancer and benign prostatic hyperplasia. Br J Urol 78: 409-413, 1996.
8. Seaman E, Whang IS, Olson CA, Katz A, Cooner WH, Benson MC: PSA density (PSAD). Role in patients evaluation and management. Urol Clin North Am 20: 653-664, 1993.
9. JM Wolff, W Boeckmann, PJ Effert, S Handt, O Jakse. Evaluation of patients with diseases of the prostate employing prostate-specific-antigen-density. Br J Urol 76: 41-45, 1995.
10. Carter HB, Parson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard JL, Walsh PC: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267: 2215-2220, 1992.
11. Christensson A, Laurell CB, Lilja H. Enzymatic activity of the prostate-specific antigen and its reaction with extracellular serine protease inhibitors. Eur J Biochem 194: 755-763, 1990.
12. Stenman UH, Leinonen J, Alfthan H, Ranniko S, Tuhkanen K, Alfthan O: A complex between prostate-specific antigen and alpha 1 antichymotrypsin is the major form of prostate-specific antigen in the serum of patients with prostate cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226, 1991.
13. Lilja H, Christensson A, Dahlen U et al: Prostate-specific antigen in serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem 37: 1618-1625, 1991.
14. Christensson A, Bjork T, Nilsson O et al: Serum prostate specific antigen complexed to al-antichymotrypsin as an indicator of prostate cancer. J Urol 150: 100-105, 1993.
15. Partin AW, Oesterling JE: The clinical usefulness of prostate-specific antigen: update 1994. J Urol 152: 1358-1368, 1994.
16. Oesterling JE, Jacobsen SJ, Cooner WH: The use of age-specific reference ranges for serum prostate specific antigen in men 60 years or older. J Urol 153: 1160-1163, 1995.
17. Oesterling JE, Jacobsen SJ, Klee GG et al: Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol 154: 1090-1095, 1995.